Ugur Sahin, BioNTech CEO (Andreas Arnold/picture-alliance/dpa/AP Images)

Covid-19 roundup: Pfiz­er/BioN­Tech say vac­cines can be stored short term at nor­mal freez­er temps; Fau­ci warns of vac­ci­na­tion de­lays in Texas

One of the biggest stick­ing points since the Pfiz­er-BioN­Tech Covid-19 vac­cine gained ap­proval has been the dras­ti­cal­ly low tem­per­a­tures vials must be stored at to main­tain their po­ten­cy and ef­fec­tive­ness.

But the two com­pa­nies an­nounced Fri­day that the -80 to -60 de­grees Cel­sius tem­per­a­tures that are cur­rent­ly re­quired to safe­ly store vac­cine dos­es may not be nec­es­sary in short­er term stor­age, and asked the FDA to up­date the vac­cine’s Emer­gency Use Au­tho­riza­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.